This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsCraftport Cannabis (CFT) 주식 개요Engages in the production and sale of recreational cannabis under the Craftport Cannabis brand in Canada. 자세히 보기CFT 펀더멘털 분석스노우플레이크 점수가치 평가0/6미래 성장0/6과거 실적0/6재무 건전성0/6배당0/6위험 분석지난 5년간 매년 수익이 18.4% 감소했습니다.의미 있는 시가총액이 없습니다(CA$3M)수익이 USD$1m 미만입니다(CA$187K)마이너스 주주 지분+ 위험 2건 추가모든 위험 점검 보기CFT Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW476,896 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA476,896 investors already sharing narrativesYour Fair ValueCA$Current PriceCA$0.0456.3% 저평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-13m1m2016201920222025202620282031Revenue CA$1.4mEarnings CA$207.8kAdvancedSet Fair ValueView all narrativesCraftport Cannabis Corp. 경쟁사Ayurcann HoldingsSymbol: CNSX:AYURMarket cap: CA$1.9mRAMM PharmaSymbol: CNSX:RAMMMarket cap: CA$1.2mCanadaBis CapitalSymbol: TSXV:CANBMarket cap: CA$2.1mDelivra Health BrandsSymbol: TSXV:DHBMarket cap: CA$3.0m가격 이력 및 성과Craftport Cannabis 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가CA$0.04552주 최고가CA$0.0652주 최저가CA$0.01베타1.171개월 변동0%3개월 변동n/a1년 변동50.00%3년 변동-97.69%5년 변동-99.33%IPO 이후 변동-99.84%최근 뉴스 및 업데이트공고 • Jul 07Craftport Cannabis Corp. Announces Appointment of Wenjie Zhang as Member of Board of DirectorsCraftport Cannabis Corp. announced that effective June 12, 2023, Ms. Wenjie Zhang has been reappointed as a member of the Company's Board of Directors in order to enhance the ability for the Company to meet Health Canada's requirements.Reported Earnings • Nov 25Third quarter 2022 earnings released: CA$0.013 loss per share (vs CA$0.036 loss in 3Q 2021)Third quarter 2022 results: CA$0.013 loss per share. Net loss: CA$738.9k (flat on 3Q 2021).공고 • Oct 04Craftport Cannabis Corp., Annual General Meeting, Dec 09, 2022Craftport Cannabis Corp., Annual General Meeting, Dec 09, 2022.Reported Earnings • Aug 30Second quarter 2022 earnings released: CA$0.029 loss per share (vs CA$0.13 loss in 2Q 2021)Second quarter 2022 results: CA$0.029 loss per share (up from CA$0.13 loss in 2Q 2021). Net loss: CA$841.1k (loss narrowed 69% from 2Q 2021).공고 • Jul 20Craftport Cannabis Corp. announced that it has received CAD 3 million in fundingOn July 19, 2022, Craftport Cannabis Corp. closed the transaction. On the same day, the company issued 18,750,000 common shares for gross proceeds of CAD 1,500,000 in its final tranche. The common shares of the company issued pursuant to the offering are subject to resale restrictions for a period of four months and a day expiring on November 19, 2022.공고 • Jul 07+ 1 more updateCraftport Cannabis Corp. Announces Executive ChangesCraftport Cannabis Corp. announce that Mr. Feng Lv has been appointed as Director of the Company. Mr. Lv replaces Michael Cosic as a director of the Company. Mr. Cosic held the CEO position since May 2021and has been a director of the Company since November 2020. He decided to step back for personal reasons.더 많은 업데이트 보기Recent updates공고 • Jul 07Craftport Cannabis Corp. Announces Appointment of Wenjie Zhang as Member of Board of DirectorsCraftport Cannabis Corp. announced that effective June 12, 2023, Ms. Wenjie Zhang has been reappointed as a member of the Company's Board of Directors in order to enhance the ability for the Company to meet Health Canada's requirements.Reported Earnings • Nov 25Third quarter 2022 earnings released: CA$0.013 loss per share (vs CA$0.036 loss in 3Q 2021)Third quarter 2022 results: CA$0.013 loss per share. Net loss: CA$738.9k (flat on 3Q 2021).공고 • Oct 04Craftport Cannabis Corp., Annual General Meeting, Dec 09, 2022Craftport Cannabis Corp., Annual General Meeting, Dec 09, 2022.Reported Earnings • Aug 30Second quarter 2022 earnings released: CA$0.029 loss per share (vs CA$0.13 loss in 2Q 2021)Second quarter 2022 results: CA$0.029 loss per share (up from CA$0.13 loss in 2Q 2021). Net loss: CA$841.1k (loss narrowed 69% from 2Q 2021).공고 • Jul 20Craftport Cannabis Corp. announced that it has received CAD 3 million in fundingOn July 19, 2022, Craftport Cannabis Corp. closed the transaction. On the same day, the company issued 18,750,000 common shares for gross proceeds of CAD 1,500,000 in its final tranche. The common shares of the company issued pursuant to the offering are subject to resale restrictions for a period of four months and a day expiring on November 19, 2022.공고 • Jul 07+ 1 more updateCraftport Cannabis Corp. Announces Executive ChangesCraftport Cannabis Corp. announce that Mr. Feng Lv has been appointed as Director of the Company. Mr. Lv replaces Michael Cosic as a director of the Company. Mr. Cosic held the CEO position since May 2021and has been a director of the Company since November 2020. He decided to step back for personal reasons.공고 • May 28Craftport Cannabis Corp. announced that it expects to receive CAD 3 million in fundingCraftport Cannabis Corp. announce a non-brokered private placement offering 37,500,000 common shares at a price of CAD 0.08 per common share for gross proceeds of CAD 3,000,000 on May 27, 2022. The company expects to close the transaction on or about June 30, 2022. On the same date the company issued 18,750,000 common shares for gross proceeds of CAD 1,500,000 in its first tranche. the common shares issued pursuant to the first tranche are subject to resale restrictions for a period of four months and a day expiring on September 28, 2022. No finders fees have been or will be paid in connection with the offering.Reported Earnings • May 05Full year 2021 earnings released: CA$0.49 loss per share (vs CA$0.55 loss in FY 2020)Full year 2021 results: CA$0.49 loss per share (up from CA$0.55 loss in FY 2020). Revenue: CA$1.01m (up 18% from FY 2020). Net loss: CA$10.1m (flat on FY 2020).공고 • Apr 09Craftport Cannabis Corp. Announces Board ChangesCraftport Cannabis Corp. announced that effective April 6, 2022, Wenjie Zhang resigned as a member of the Company's Board of Directors in order to allow her to focus on her other professional duties. The Company also announced that, effective April 6, 2022, Yuan Gao was appointed to the Company's Board of Directors. Gao has been employed by the Company since March 2021, and as such, has a deep understanding of the Company's operations.공고 • Jan 26Craftport Cannabis Corp. announced that it expects to receive CAD 3 million in fundingCraftport Cannabis Corp. announce a non-brokered private placement offering of up to 15,000,000 common shares at a price of CAD 0.20 per common share for gross proceeds of CAD 3,000,000 on January 25, 2022. The offering price of CAD 0.20 represents a 25% premium to the company's last closing price on the Canadian Securities Exchange on January 24, 2022 of CAD 0.16 per common share. The common shares issued pursuant to the offering will be subject to resale restrictions for a period of four months and a day from the date of issuance. The closing of the transaction is subject to certain customary conditions, including Canadian Securities Exchange approval. No finders’ fees will be paid in connection with the transaction. The company expects to close the offering by March 8, 2022.Reported Earnings • Nov 29Third quarter 2021 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2021 results: CA$0.036 loss per share (down from CA$0.001 profit in 3Q 2020). Revenue: CA$317.9k (up 2.5% from 3Q 2020). Net loss: CA$734.2k (down CA$755.6k from profit in 3Q 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has fallen by 56% per year, which means it is performing significantly worse than earnings.분석 기사 • Nov 25Does Craftport Cannabis (CSE:CFT) Have A Healthy Balance Sheet?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Board Change • Nov 24Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Chairman George Dorin was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • May 31First quarter 2021 earnings released: CA$0.004 loss per share (vs CA$0.005 loss in 1Q 2020)First quarter 2021 results: Net loss: CA$739.8k (loss narrowed 15% from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 62% per year, which means it is performing significantly worse than earnings.분석 기사 • May 19We Think Benchmark Botanics (CSE:BBT) Has A Fair Chunk Of DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...공고 • Mar 20Benchmark Botanics Inc. Announces Board ChangesBenchmark Botanics Inc. announced that the company has determined that a new CEO would be beneficial in leading Benchmark to the next stage of its growth. To that end, effective immediately, Mr. William Ying has resigned as the Company's Chief Executive Officer and board of director. Benchmark to the next stage of its growth. To that end, effective immediately, Mr. William Ying has resigned as the Company's Chief Executive Officer and board of director. Mr. Terry Wang has been appointed as the Company's Interim Chief Executive Officer as the Board engages in a process to identify a permanent CEO.공고 • Mar 19Benchmark Botanics Inc. Announces Executive ChangesBenchmark Botanics Inc. announced that the company has determined that a new CEO would be beneficial in leading Benchmark to the next stage of its growth. To that end, effective immediately, Mr. William Ying has resigned as the Company's Chief Executive Officer and board of director. Benchmark to the next stage of its growth. To that end, effective immediately, Mr. William Ying has resigned as the Company's Chief Executive Officer and board of director. Mr. Terry Wang has been appointed as the Company's Interim Chief Executive Officer as the Board engages in a process to identify a permanent CEO.분석 기사 • Nov 29Benchmark Botanics (CSE:BBT) Is Making Moderate Use Of DebtThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...공고 • Nov 18Benchmark Botanics, Inc. Announces Appointment of Mike Cosic to Board of DirectorsBenchmark Botanics Inc. announced the appointment of Mr. Mike Cosic to the Company's board of directors. Mr. Cosic is currently the CFO of Meta Growth Corp. He was previously the CFO at both DLT Labs Inc. and Lithium Americas Corp., and currently sits on the Board of Directors and is Audit Committee Chairman of Eastern Platinum Limited.공고 • Nov 17Benchmark Botanics Inc. Announces Resignation of James Moore as DirectorBenchmark Botanics Inc. announces that Mr. James Moore has resigned from its Board of Directors. The Board has accepted Mr. Moore's resignation and wishes to thank Mr. Moore for his service and dedication to the Company.공고 • Nov 06Benchmark Botanics Inc. Announces CFO ChangesBenchmark Botanics Inc. appointed David Li, MBA, CPA-IL, as its new Chief Financial Officer. Mr. Li will be replacing Paul Haber in this role. David Li comes to Benchmark with a wealth of public company expertise having helped many companies successfully navigate the capital markets.공고 • Sep 02Benchmark Botanics Inc. (CNSX:BBT) completed the acquisition of additional 25.9% stake in 1139000 B.C. Ltd. from shareholders.Benchmark Botanics Inc. (CNSX:BBT) entered into a share exchange agreement to acquire additional 25.9% stake in 1139000 B.C. Ltd. from shareholders for CAD 5.4 million on July 7, 2020. The consideration includes issuance of 30 million shares by Benchmark in exchange for 5.2 million Common shares of 1139000. Benchmark currently owns 5 million Common shares of 1139000 and after completion of the transactions contemplated under the Agreement, Benchmark will own 10,199,000 Common shares, which will represent 51% of issued and outstanding share capital of 1139000. Closing of the transactions is subject to compliance with the requirements of the Canadian Securities Exchange and applicable securities laws. The transaction is expected to close on August 15, 2020. Benchmark Botanics Inc. (CNSX:BBT) completed the acquisition of additional 25.9% stake in 1139000 B.C. Ltd. from shareholders on August 31, 2020. All consideration shares issued are subject to a statutory hold period expiring four months and one day after the closing of the transaction.공고 • Aug 12Benchmark Botanics Inc. (CNSX:BBT) entered into a share exchange agreement to acquire additional 25.9% stake in 1139000 B.C. Ltd. from shareholders for $5.4 million.Benchmark Botanics Inc. (CNSX:BBT) entered into a share exchange agreement to acquire additional 25.9% stake in 1139000 B.C. Ltd. from shareholders for $5.4 million on August 11, 2020. Benchmark currently owns 5 million Common shares of 1139000 and after completion of the transactions contemplated under the Agreement, Benchmark will own 10,199,000 Common shares, which will represent 51% of issued and outstanding share capital of 1139000. The consideration includes issuance of 26.9 million shares by Benchmark in exchange for their 5.2 million Common shares of 1139000. The transaction is expected to close on August 15, 2020.주주 수익률CFTCA PharmaceuticalsCA 시장7D0%3.6%2.2%1Y50.0%9.6%31.2%전체 주주 수익률 보기수익률 대 산업: CFT은 지난 1년 동안 9.6%의 수익을 기록한 Canadian Pharmaceuticals 산업보다 더 좋은 성과를 냈습니다.수익률 대 시장: CFT은 지난 1년 동안 31.2%를 기록한 Canadian 시장보다 더 좋은 성과를 냈습니다.주가 변동성Is CFT's price volatile compared to industry and market?CFT volatilityCFT Average Weekly Movementn/aPharmaceuticals Industry Average Movement8.5%Market Average Movement9.7%10% most volatile stocks in CA Market16.1%10% least volatile stocks in CA Market3.7%안정적인 주가: CFT는 지난 3개월 동안 Canadian 시장에 비해 주가 변동성이 크지 않았습니다.시간에 따른 변동성: Insufficient data to determine CFT의 변동성 변화를 판단할 수 없습니다.회사 소개설립직원 수CEO웹사이트n/an/aFeng Luwww.craftportcannabis.com더 보기Craftport Cannabis Corp. 기초 지표 요약Craftport Cannabis의 순이익과 매출은 시가총액과 어떻게 비교됩니까?CFT 기초 통계시가총액CA$2.65m순이익 (TTM)-CA$8.34m매출 (TTM)CA$187.27k14.2x주가매출비율(P/S)-0.3x주가수익비율(P/E)CFT는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표CFT 손익계산서 (TTM)매출CA$187.27k매출원가CA$674.14k총이익-CA$486.86k기타 비용CA$7.85m순이익-CA$8.34m최근 보고된 실적Sep 30, 2022다음 실적 발표일해당 없음주당순이익(EPS)-0.14총이익률-259.98%순이익률-4,454.14%부채/자본 비율-292.7%CFT의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2023/08/06 18:40종가2023/05/09 00:00수익2022/09/30연간 수익2021/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Craftport Cannabis Corp.는 0명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공고 • Jul 07Craftport Cannabis Corp. Announces Appointment of Wenjie Zhang as Member of Board of DirectorsCraftport Cannabis Corp. announced that effective June 12, 2023, Ms. Wenjie Zhang has been reappointed as a member of the Company's Board of Directors in order to enhance the ability for the Company to meet Health Canada's requirements.
Reported Earnings • Nov 25Third quarter 2022 earnings released: CA$0.013 loss per share (vs CA$0.036 loss in 3Q 2021)Third quarter 2022 results: CA$0.013 loss per share. Net loss: CA$738.9k (flat on 3Q 2021).
공고 • Oct 04Craftport Cannabis Corp., Annual General Meeting, Dec 09, 2022Craftport Cannabis Corp., Annual General Meeting, Dec 09, 2022.
Reported Earnings • Aug 30Second quarter 2022 earnings released: CA$0.029 loss per share (vs CA$0.13 loss in 2Q 2021)Second quarter 2022 results: CA$0.029 loss per share (up from CA$0.13 loss in 2Q 2021). Net loss: CA$841.1k (loss narrowed 69% from 2Q 2021).
공고 • Jul 20Craftport Cannabis Corp. announced that it has received CAD 3 million in fundingOn July 19, 2022, Craftport Cannabis Corp. closed the transaction. On the same day, the company issued 18,750,000 common shares for gross proceeds of CAD 1,500,000 in its final tranche. The common shares of the company issued pursuant to the offering are subject to resale restrictions for a period of four months and a day expiring on November 19, 2022.
공고 • Jul 07+ 1 more updateCraftport Cannabis Corp. Announces Executive ChangesCraftport Cannabis Corp. announce that Mr. Feng Lv has been appointed as Director of the Company. Mr. Lv replaces Michael Cosic as a director of the Company. Mr. Cosic held the CEO position since May 2021and has been a director of the Company since November 2020. He decided to step back for personal reasons.
공고 • Jul 07Craftport Cannabis Corp. Announces Appointment of Wenjie Zhang as Member of Board of DirectorsCraftport Cannabis Corp. announced that effective June 12, 2023, Ms. Wenjie Zhang has been reappointed as a member of the Company's Board of Directors in order to enhance the ability for the Company to meet Health Canada's requirements.
Reported Earnings • Nov 25Third quarter 2022 earnings released: CA$0.013 loss per share (vs CA$0.036 loss in 3Q 2021)Third quarter 2022 results: CA$0.013 loss per share. Net loss: CA$738.9k (flat on 3Q 2021).
공고 • Oct 04Craftport Cannabis Corp., Annual General Meeting, Dec 09, 2022Craftport Cannabis Corp., Annual General Meeting, Dec 09, 2022.
Reported Earnings • Aug 30Second quarter 2022 earnings released: CA$0.029 loss per share (vs CA$0.13 loss in 2Q 2021)Second quarter 2022 results: CA$0.029 loss per share (up from CA$0.13 loss in 2Q 2021). Net loss: CA$841.1k (loss narrowed 69% from 2Q 2021).
공고 • Jul 20Craftport Cannabis Corp. announced that it has received CAD 3 million in fundingOn July 19, 2022, Craftport Cannabis Corp. closed the transaction. On the same day, the company issued 18,750,000 common shares for gross proceeds of CAD 1,500,000 in its final tranche. The common shares of the company issued pursuant to the offering are subject to resale restrictions for a period of four months and a day expiring on November 19, 2022.
공고 • Jul 07+ 1 more updateCraftport Cannabis Corp. Announces Executive ChangesCraftport Cannabis Corp. announce that Mr. Feng Lv has been appointed as Director of the Company. Mr. Lv replaces Michael Cosic as a director of the Company. Mr. Cosic held the CEO position since May 2021and has been a director of the Company since November 2020. He decided to step back for personal reasons.
공고 • May 28Craftport Cannabis Corp. announced that it expects to receive CAD 3 million in fundingCraftport Cannabis Corp. announce a non-brokered private placement offering 37,500,000 common shares at a price of CAD 0.08 per common share for gross proceeds of CAD 3,000,000 on May 27, 2022. The company expects to close the transaction on or about June 30, 2022. On the same date the company issued 18,750,000 common shares for gross proceeds of CAD 1,500,000 in its first tranche. the common shares issued pursuant to the first tranche are subject to resale restrictions for a period of four months and a day expiring on September 28, 2022. No finders fees have been or will be paid in connection with the offering.
Reported Earnings • May 05Full year 2021 earnings released: CA$0.49 loss per share (vs CA$0.55 loss in FY 2020)Full year 2021 results: CA$0.49 loss per share (up from CA$0.55 loss in FY 2020). Revenue: CA$1.01m (up 18% from FY 2020). Net loss: CA$10.1m (flat on FY 2020).
공고 • Apr 09Craftport Cannabis Corp. Announces Board ChangesCraftport Cannabis Corp. announced that effective April 6, 2022, Wenjie Zhang resigned as a member of the Company's Board of Directors in order to allow her to focus on her other professional duties. The Company also announced that, effective April 6, 2022, Yuan Gao was appointed to the Company's Board of Directors. Gao has been employed by the Company since March 2021, and as such, has a deep understanding of the Company's operations.
공고 • Jan 26Craftport Cannabis Corp. announced that it expects to receive CAD 3 million in fundingCraftport Cannabis Corp. announce a non-brokered private placement offering of up to 15,000,000 common shares at a price of CAD 0.20 per common share for gross proceeds of CAD 3,000,000 on January 25, 2022. The offering price of CAD 0.20 represents a 25% premium to the company's last closing price on the Canadian Securities Exchange on January 24, 2022 of CAD 0.16 per common share. The common shares issued pursuant to the offering will be subject to resale restrictions for a period of four months and a day from the date of issuance. The closing of the transaction is subject to certain customary conditions, including Canadian Securities Exchange approval. No finders’ fees will be paid in connection with the transaction. The company expects to close the offering by March 8, 2022.
Reported Earnings • Nov 29Third quarter 2021 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2021 results: CA$0.036 loss per share (down from CA$0.001 profit in 3Q 2020). Revenue: CA$317.9k (up 2.5% from 3Q 2020). Net loss: CA$734.2k (down CA$755.6k from profit in 3Q 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has fallen by 56% per year, which means it is performing significantly worse than earnings.
분석 기사 • Nov 25Does Craftport Cannabis (CSE:CFT) Have A Healthy Balance Sheet?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Board Change • Nov 24Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Chairman George Dorin was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • May 31First quarter 2021 earnings released: CA$0.004 loss per share (vs CA$0.005 loss in 1Q 2020)First quarter 2021 results: Net loss: CA$739.8k (loss narrowed 15% from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 62% per year, which means it is performing significantly worse than earnings.
분석 기사 • May 19We Think Benchmark Botanics (CSE:BBT) Has A Fair Chunk Of DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
공고 • Mar 20Benchmark Botanics Inc. Announces Board ChangesBenchmark Botanics Inc. announced that the company has determined that a new CEO would be beneficial in leading Benchmark to the next stage of its growth. To that end, effective immediately, Mr. William Ying has resigned as the Company's Chief Executive Officer and board of director. Benchmark to the next stage of its growth. To that end, effective immediately, Mr. William Ying has resigned as the Company's Chief Executive Officer and board of director. Mr. Terry Wang has been appointed as the Company's Interim Chief Executive Officer as the Board engages in a process to identify a permanent CEO.
공고 • Mar 19Benchmark Botanics Inc. Announces Executive ChangesBenchmark Botanics Inc. announced that the company has determined that a new CEO would be beneficial in leading Benchmark to the next stage of its growth. To that end, effective immediately, Mr. William Ying has resigned as the Company's Chief Executive Officer and board of director. Benchmark to the next stage of its growth. To that end, effective immediately, Mr. William Ying has resigned as the Company's Chief Executive Officer and board of director. Mr. Terry Wang has been appointed as the Company's Interim Chief Executive Officer as the Board engages in a process to identify a permanent CEO.
분석 기사 • Nov 29Benchmark Botanics (CSE:BBT) Is Making Moderate Use Of DebtThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
공고 • Nov 18Benchmark Botanics, Inc. Announces Appointment of Mike Cosic to Board of DirectorsBenchmark Botanics Inc. announced the appointment of Mr. Mike Cosic to the Company's board of directors. Mr. Cosic is currently the CFO of Meta Growth Corp. He was previously the CFO at both DLT Labs Inc. and Lithium Americas Corp., and currently sits on the Board of Directors and is Audit Committee Chairman of Eastern Platinum Limited.
공고 • Nov 17Benchmark Botanics Inc. Announces Resignation of James Moore as DirectorBenchmark Botanics Inc. announces that Mr. James Moore has resigned from its Board of Directors. The Board has accepted Mr. Moore's resignation and wishes to thank Mr. Moore for his service and dedication to the Company.
공고 • Nov 06Benchmark Botanics Inc. Announces CFO ChangesBenchmark Botanics Inc. appointed David Li, MBA, CPA-IL, as its new Chief Financial Officer. Mr. Li will be replacing Paul Haber in this role. David Li comes to Benchmark with a wealth of public company expertise having helped many companies successfully navigate the capital markets.
공고 • Sep 02Benchmark Botanics Inc. (CNSX:BBT) completed the acquisition of additional 25.9% stake in 1139000 B.C. Ltd. from shareholders.Benchmark Botanics Inc. (CNSX:BBT) entered into a share exchange agreement to acquire additional 25.9% stake in 1139000 B.C. Ltd. from shareholders for CAD 5.4 million on July 7, 2020. The consideration includes issuance of 30 million shares by Benchmark in exchange for 5.2 million Common shares of 1139000. Benchmark currently owns 5 million Common shares of 1139000 and after completion of the transactions contemplated under the Agreement, Benchmark will own 10,199,000 Common shares, which will represent 51% of issued and outstanding share capital of 1139000. Closing of the transactions is subject to compliance with the requirements of the Canadian Securities Exchange and applicable securities laws. The transaction is expected to close on August 15, 2020. Benchmark Botanics Inc. (CNSX:BBT) completed the acquisition of additional 25.9% stake in 1139000 B.C. Ltd. from shareholders on August 31, 2020. All consideration shares issued are subject to a statutory hold period expiring four months and one day after the closing of the transaction.
공고 • Aug 12Benchmark Botanics Inc. (CNSX:BBT) entered into a share exchange agreement to acquire additional 25.9% stake in 1139000 B.C. Ltd. from shareholders for $5.4 million.Benchmark Botanics Inc. (CNSX:BBT) entered into a share exchange agreement to acquire additional 25.9% stake in 1139000 B.C. Ltd. from shareholders for $5.4 million on August 11, 2020. Benchmark currently owns 5 million Common shares of 1139000 and after completion of the transactions contemplated under the Agreement, Benchmark will own 10,199,000 Common shares, which will represent 51% of issued and outstanding share capital of 1139000. The consideration includes issuance of 26.9 million shares by Benchmark in exchange for their 5.2 million Common shares of 1139000. The transaction is expected to close on August 15, 2020.
